Toxin A News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Data from the phase 3 study confirmed the lot consistency, immunogenicity, safety, and tolerability of a toxoid-based Clostridioides difficile vaccine.

Shane christensenJ lewis researchFoothill family clinicC diffClostridioides difficileAntibody responseToxin aToxin b